These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49. Quetiapine augmentation of serotonin reuptake inhibitors in obsessive-compulsive disorder. Mohr N; Vythilingum B; Emsley RA; Stein DJ Int Clin Psychopharmacol; 2002 Jan; 17(1):37-40. PubMed ID: 11800505 [TBL] [Abstract][Full Text] [Related]
50. A meta-analysis of dropout rates from exposure with response prevention and pharmacological treatment for youth with obsessive compulsive disorder. Johnco C; McGuire JF; Roper T; Storch EA Depress Anxiety; 2020 May; 37(5):407-417. PubMed ID: 31778595 [TBL] [Abstract][Full Text] [Related]
51. Female hormones affect symptom severity in obsessive-compulsive disorder. Vulink NC; Denys D; Bus L; Westenberg HG Int Clin Psychopharmacol; 2006 May; 21(3):171-5. PubMed ID: 16528139 [TBL] [Abstract][Full Text] [Related]
52. Obsessive-compulsive disorder in schizophrenia: clinical characteristics and treatment. Poyurovsky M; Weizman A; Weizman R CNS Drugs; 2004; 18(14):989-1010. PubMed ID: 15584769 [TBL] [Abstract][Full Text] [Related]
53. A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder. McDougle CJ; Epperson CN; Pelton GH; Wasylink S; Price LH Arch Gen Psychiatry; 2000 Aug; 57(8):794-801. PubMed ID: 10920469 [TBL] [Abstract][Full Text] [Related]
54. Quetiapine addition to serotonin reuptake inhibitors in patients with severe obsessive-compulsive disorder: a double-blind, randomized, placebo-controlled study. Kordon A; Wahl K; Koch N; Zurowski B; Anlauf M; Vielhaber K; Kahl KG; Broocks A; Voderholzer U; Hohagen F J Clin Psychopharmacol; 2008 Oct; 28(5):550-4. PubMed ID: 18794652 [TBL] [Abstract][Full Text] [Related]
55. Pharmacotherapies in the management of obsessive-compulsive disorder. Blier P; Habib R; Flament MF Can J Psychiatry; 2006 Jun; 51(7):417-30. PubMed ID: 16838823 [TBL] [Abstract][Full Text] [Related]
57. A review of antipsychotics in the treatment of obsessive compulsive disorder. Fineberg NA; Gale TM; Sivakumaran T J Psychopharmacol; 2006 Jan; 20(1):97-103. PubMed ID: 16204331 [No Abstract] [Full Text] [Related]
58. Metabolic and toxicological considerations for obsessive-compulsive disorder drug therapy. Sayyah M; Majzoob S; Sayyah M Expert Opin Drug Metab Toxicol; 2013 Jun; 9(6):657-73. PubMed ID: 23521155 [TBL] [Abstract][Full Text] [Related]